STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3171 by analyst upside · 2026-08-13
MMSI
Merit Medical Systems, Inc.
Healthcare · Market Cap $5B · P/E 37.4x
ANALYST PRICE TARGET
+9.4%
implied upside to consensus target
Current Price $91.2
Consensus Target $99.82
Bull Target $114.0
Bear Target $83.0
Analysts Covering 11
ANALYST CONSENSUS - BUY
Strong Buy
5
Buy
4
Hold
2
Sell
0
52-Week Low $59.74
52-Week High $94.75
YTD Return +5.5%
FUNDAMENTALS
Market Cap $5B
P/E Ratio (TTM) 37.4x
Forward P/E 19.8x
EPS (TTM) $2.44
PEG Ratio 1.81
Dividend Yield N/A
Revenue (TTM) $1.6B
Profit Margin 9.2%
52-WEEK RANGE
52-Week Low $59.74
52-Week High $94.75
Current Price $91.2
Bear Target $83.0
Bull Target $114.0
● Now $91.2 ● Target $99.82
TRADING DATA
Avg Volume 903K
YTD Return +5.5%
Analyst Count 11
Consensus Buy
Upside to Target +9.4%
Last Updated 2026-08-13

ANALYST SUMMARY

Merit Medical Systems, Inc. (MMSI) is currently trading at $91.2 with a Wall Street consensus price target of $99.82, implying potential upside of 9.4% over the next 12 months. 11 analysts currently cover MMSI, with a consensus rating of Buy - 82% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $114.0, while the most cautious has a target of $83.0.

MMSI operates in the Healthcare sector with a market capitalisation of $5B. The stock is up 5.5% year-to-date and is currently trading near the upper end of its 52-week range of $59.74 – $94.75.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MMSI, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity - Reiterated
Buy → Buy 2026-05-01 Building track record
JP Morgan - Reiterated
Overweight → Overweight 2026-05-01 43% win rate (7 calls)
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-05-01 Building track record
Needham - Reiterated
Buy → Buy 2026-05-01 20% win rate (5 calls)
Barrington Research - Reiterated
Outperform → Outperform 2026-04-20 Building track record
Piper Sandler - Reiterated
Overweight → Overweight 2026-04-17 14% win rate (7 calls)
Canaccord Genuity - Reiterated
Buy → Buy 2026-04-07 Building track record
Needham reit
Buy → Buy 2026-04-01 20% win rate (5 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
64
out of 100
Coverage depth
19/30
Consensus clarity
23/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →